Autonomix Medical raises $10.0M in underwritten public offering of common and pre-funded units

Autonomix Medical, Inc.

Gross proceeds of ~$10.0M from 615,500 common units (incl. 156,809 over-allotment) and 917,596 pre-funded units.
Price per common unit $6.54; per pre-funded unit $6.539; each includes a Series A warrant exercisable at $6.54 for 5 years.
Underwriters partially exercised over-allotment for 156,809 shares and Series A warrants.
Net proceeds to fund clinical trial, R&D, IP development, and working capital.
Ladenburg Thalmann sole bookrunner; offering closed Nov 25, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.